References
- Furukawa H, Cordova KE, O’Keeffe M, et al. The Chemistry and Applications of Metal-Organic Frameworks. Science. 2013;341(6149):1230444.
- Doonan C, Riccò R, Liang K, et al. Metal–Organic frameworks at the biointerface: synthetic strategies and applications. Acc Chem Res. 2017;50(6):1423–1432.
- Jiao L, Seow JYR, Skinner WS, et al. Metal–Organic Frameworks: structures and Functional Applications. Mater Today. 2019;27:43–68.
- Campagnol N, Souza ER, De Vos DE, et al. Luminescent Terbium-Containing Metal–Organic Framework Films: new Approaches for the Electrochemical Synthesis and Application as Detectors for Explosives. Chem Commun. 2014;50(83):12545–12547.
- Zhang Y, Bo X, Nsabimana A, et al. Electrocatalytically Active Cobalt-Based Metal–Organic Framework with Incorporated Macroporous Carbon Composite for Electrochemical Applications. J Mat Chem A. 2015;3(2):732–738.
- Tseng YJ, Wu JY. Reversible Structural Transformations between a Chain Polymer and a Metallocage Induced by Anion Templation. Inorganica Chim Acta. 2017;455:241–246.
- Fang M, Wu C, Yang Z, et al. ZIF-8/PDMS Mixed Matrix Membranes for Propane/Nitrogen Mixture Separation: experimental Result and Permeation Model Validation. Journal of Membrane Science. 2015;474:103–113.
- Vasconcelos IB, Silva TG, Gcg M, et al. Cytotoxicity and Slow Release of the Anti-Cancer Drug Doxorubicin from ZIF-8. RSC Adv. 2012;2(25):9437–9442.
- Wang HS. Metal–Organic Frameworks for Biosensing and Bioimaging Applications. Coord Chem Rev. 2017;349:139–155.
- Yap MH, Fow KL, Chen GZ. Synthesis and Applications of MOF-Derived Porous Nanostructures. Green Energy Environ. 2017;2(3):218–245.
- Sun CY, Qin C, Wang XL, et al. Metal-Organic Frameworks as Potential Drug Delivery Systems. Expert Opin Drug Deliv. 2013;10(1):89–101.
- Zhuang J, Young AP, Tsung CK. Integration of Biomolecules with Metal-Organic Frameworks. Small. 2017;13(32):1700880.
- Torre LA, Siegel RL, Ward EM, et al. Global Cancer Incidence and Mortality Rates and Trends–An Update. Cancer Epidemiol Biomarkers Prev. 2016;25(1):16–27.
- Young MRI. Redirecting the focus of cancer immunotherapy to premalignant conditions. Cancer Lett. 2017;10(391):83–88.
- Cai M, Chen G, Qin L, et al. Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancer. Pharmaceutics. 2020;12(3):232. .
- Fairen-Jimenez D, Kaminski Schierle G, Teplensky M, et al. Metal organic framework-based compositions and uses thereof [Internet]. (WO2019086542), 2019. Avaliable from https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20190509&CC=WO&NR=2019086542A1&KC=A1
- Yl KS, Goo HC Metal-organic framework composition preparing method thereof drug including composition thereof and drug delivery vehicle thereof [Internet]. (KR20160124398), 2016. Available from https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20161027&CC=KR&NR=20160124398A&KC=A
- Wang Z, Qiao C, Zhang R, et al. Surface functionalization modification method for metal organic framework (MOF) material based on liposome membrane [Internet]. (CN107189074), 2017. Available from https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20170922&CC=CN&NR=107189074A&KC=A
- Husseini G, Sabouni R, Ibrahim M Ultrasound triggered release from metal organic framework nanocarriers [Internet]. (US2019247502), 2019. Available from https://worldwide.espacenet.com/publicationDetails/biblio?CC=US&NR=2019247502A1&KC=A1&FT=D&ND=3&date=20190815&DB=&locale=en_EP
- Wang H, Zhu W, Li Z, et al. Preparation method of metal polyphenol vesicle material with micrometer/nanometer multilayer composite structure [Internet]. (CN106565964), 2017. Avaliable from https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20170419&CC=CN&NR=106565964A&KC=A
- Oliveira-Júnior RG, Bonnet A, Braconnier E, et al. Bixin, an apocarotenoid isolated from Bixa orellana L., sensitizes human melanoma cells to dacarbazine-induced apoptosis through ROS-mediated cytotoxicity. Food Chem Toxicol. 2019;125:549–561.
- Oliveira-Júnior RG, Ferraz CAA, Pereira ECV, et al. Phytochemical Analysis and Cytotoxic Activity of Cnidoscolus quercifolius Pohl (Euphorbiaceae) against Prostate (PC3 and PC3‑M) and Breast (MCF‑7) Cancer Cells. Pharmacogn Mag. 2019;15(60):24–28.
- Rocha SMM, Cardoso PCS, Bahia MO, et al. Effect of the kaurenoic acid on genotoxicity and cell cycle progression in cervical cancer cells lines. Toxicol in Vitro. 2019;57:126–131.
- Cja S-F, Freitas PGC, Oliveira FCE, et al. Nanoencapsulation of triterpene 3β,6β,16β-trihydroxylup-20(29)-ene from Combretum leprosum as strategy to improve its cytotoxicity against cancer cell lines. Bioorg Med Chem Lett. 2020;30(20):127469.
- Oliveira AP, Silva ALN, Viana LGFC, et al. β-Cyclodextrin complex improves the bioavailability and antitumor potential of cirsiliol, a flavone isolated from Leonotis nepetifolia (Lamiaceae). Heliyon 2019;5(10):e01692.
- Amantino CF, Baptista-Neto A, Badino AC, et al. Anthraquinone encapsulation into polymeric nanocapsules as a new drug from biotechnological origin designed for photodynamic therapy. Photodiagnosis Photodyn Ther. 2020;31:101815.
- Simão DO, Honorato TD, Gobo GG, et al. Preparation and cytotoxicity of lipid nanocarriers containing a hydrophobic flavanone. Colloid Surface A. 2020;601:124982.
- Zheng S, Gong C Nanoparticle for protein delivery [Internet]. (WO2019227091), 2019. Available from https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20191128&CC=WO&NR=2019227091A1&KC=A1
- Veenendaal LM, Jin H, Ran S, et al. In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors. PNAS. 2002;99(12):7866–7871.
- Chu TC, Marks-III JW, Lavery LA, et al. Aptamer: Toxin Conjugates that Specifically Target Prostate Tumor Cells. Cancer Res. 2006;66(12):5989–5992.
- Issa MCA, Manela-Azulay M. Terapia fotodinâmica: revisão da literatura e documentação iconográfica. An Bras Dermatol. 2010;85(4):501–511. Avaiable from: https://www.scielo.br/pdf/abd/v85n4/v85n4a11.pdf 10.1590/S0365-05962010000400011
- Prażmo EJ, Kwaśny M, Łapiński M, et al. Photodynamic therapy as a promising method used in the treatment of oral diseases. Adv Clin Exp Med. 2016;25(4):799–807.
- Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol. 1998;134(2):207–214.
- Zhang Q, Li L. Photodynamic combinational therapy in cancer treatment. JBUON. 2018;23(3):561–567. Avaliable from: https://www.jbuon.com/archive/23-3-561.pdf
- Chambrone L, Wang HL, Romanos GE. Antimicrobial photodynamic therapy for the treatment of periodontitis and peri-implantitis: an American Academy of Periodontology best evidence review. J Periodontol. 2018;89(7):783–803.
- Fritsch C, Lang K, Neuse W, et al. Photodynamic Diagnosis and Therapy in Dermatology. Skin Pharmacol Physiol. 1998;11(6):358–373.
- Dobson J, Queiroz GF, Golding JP. Photodynamic therapy and diagnosis: principles and comparative aspects. Vet J. 2018;233:8–18.
- He D, Xu Y, Zhang Z, et al. Preparation method of pH sensitive and photothermal therapeutic probe based on metal organic framework ZIF-8 [Internet]. (CN109529036), 2019. Available from https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20190329&CC=CN&NR=109529036A&KC=A
- Nie G, Zhang L, Li L, et al. MOF-manganese dioxide microspheres, and preparation method and application thereof [Internet]. (CN108219155), 2018. Available from https://worldwide.espacenet.com/publicationDetails/biblio?CC=CN&NR=108219155A&KC=A&FT=D&ND=3&date=20180629&DB=&locale=en_EP
- Saumya S, Saloni J, Deepak K, et al. A Review on -Theranostics: an Approach to Targeted Diagnosis and Therapy. AJPRD. 2019;7(2):63–69.
- Thangadurai M, Nalliapan G, Janardhanam DS, et al. Theranostics an emerging paradigm- a review. IOSR J Dental Med Sci. 2018;17(11):01–07.
- Ramanathan S, Archunan G, Sivakumar M, et al. Theranostic applications of nanoparticles in neurodegenerative disorders. Int J Nanomedicine. 2018;13:5561–5576.
- Sikkandhar MG, Nedumaran AM, Ravichandar R, et al. Theranostic probes for targeting tumor microenvironment: an overview. Int J Mol Sci. 2017;18(5):1036.
- Fu Y, Zou Q, Zhang X, et al. Magnetic resonance imaging guided targeting metal organic framework drug carrier preparation method [Internet]. (CN104815340), 2015. Available from https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20150805&CC=CN&NR=104815340A&KC=A
- Sun L, Ling D, Li H, et al. Preparation method and application of pH-responsive dual-drug-release metal-organic framework-upconversion nano-system [Internet]. (CN109172587), 2019. Available from https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20190111&CC=CN&NR=109172587A&KC=A
- Hayes MT. Parkinson’s Disease and Parkinsonism. Am J Med. 2019;132(7):802–807.
- Cabreira V, Parkinson’s Disease MJ, Review C. Update. Acta Med Port. 2019;32(10):661–670.
- Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257–1272.
- Li Q, Li Q, Bai S, et al. Metal-organic framework-superoxide dismutase assembly, preparation method and application thereof in preparation of drugs for treating Parkinson [Internet]. (CN109833468), 2019. Available from https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20190604&CC=CN&NR=109833468A&KC=A
- Beitz JM. Parkinson’s disease: a review. Front Biosci (Schol Ed). 2014;1(6):65–74.
- Lotanka S, Prabhavalka KS, Bhatt LK. Biomarkers for parkinson’s disease: recent advancement. Neurosci Bull. 2017;33(5):585–597.
- Opara JA, Małecki A, Małecka E, et al. Motor assessment in parkinson`s disease. ann. Agric Environ Med. 2017;24(3):411–415.
- Miao L, Clair DKS. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med. 2009;47(4):344–356.
- Nozik-Grayck E, Suliman HB, Piantadosi CA. Extracellular superoxide dismutase. Int J Biochem Cell Biol. 2005;37(12):2466–2471.
- Guarner J. Chagas disease as example of a reemerging parasite. Semin Diagn Pathol. 2019;36(3):164–169.
- Antinori S, Galimberti L, Bianco R, et al. Chagas disease in Europe: a review for the internist in the globalized world. European Journal of Internal Medicine. 2017;43:6–15.
- Samuels AM, Clark EH, Galdos-Cardenas G, et al. Epidemiology of and impact of insecticide spraying on chagas disease in communities in the bolivian chaco. PLoS Negl Trop Dis. 2013;7(8):e2358.
- Pérez-Molina JA, Molina I. Chagas disease. Lancet 2018;391(10115):82–94.
- Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis. 2001;1(2):92–100.
- Bern C, Martin DL, Gilman RH. Acute and congenital Chagas disease. Adv Parasitol. 2011;75:19–47.
- Marin-Neto JA, Almeida Filho OC, Pazin-Filho A, et al. [Indeterminate form of chagas’ disease. proposal of new diagnostic criteria and perspectives for early treatment of cardiomyopathy]. Arq Bras Cardiol. 2002;79(6):623–627.
- Dias JC. The indeterminate form of human chronic Chagas’ disease. A clinical epidemiological review. Rev Soc Bras Med Trop. 1989;22(3):147–156.
- Coura JR, Borges-Pereira J. Chagas disease: 100 years after its discovery. A systemic review. Acta Trop. 2010;115(1–2):5–13.
- Rassi JA, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010;375(9723):1388–1402.
- Jr. RA, Rassi A, Rassi SG. Predictors of mortality in chronic chagas disease: a systematic review of observational studies. Circulation 2007;115(1101–1108):1.
- Rolim Neto PJ, Ferraz LRM, Alves AEG, et al. Formulações farmacêuticas contendo associação de benznidazol e MOF’s para obtenção tecnológica de sistemas drug delivery. (BR102016003408), 2016. Avaliable from https://patentscope.wipo.int/search/pt/detail.jsf?docId=BR217857771&_cid=P20-KDLYCE–47781–1
- Chia-Kuang T, Jeffery B, Chia-Kuang T, et al. Molecular encapsulation in metal-organic framework crystals. (US2017232420), 2017. Available from https://worldwide.espacenet.com/publicationDetails/biblio?II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20170817&CC=US&NR=2017232420A1&KC=A1
- Zehentbauer FM, Moretto C, Stephen R, et al. Fluorescence spectroscopy of Rhodamine 6G: concentration and solvent effects. Spectrochim Acta A Mol Biomol Spectrosc. 2014;121:147–151.
- Manjubaashini N, Kesavan MP, Rajesh J, et al. Multispectroscopic and bioimaging approach for the interaction of rhodamine 6G capped gold nanoparticles with bovine serum albumin. J Photochem Photobiol B. 2018;183:374–384.
- Li Z, Potter N, Rasmussen J, et al. Removal of rhodamine 6G with different types of clay minerals. Chemosphere 2018;202:127–135.
- Jaworska A, Wojcik T, Malek K, et al. Rhodamine 6G conjugated to gold nanoparticles as labels for both SERS and fluorescence studies on live endothelial cells. Mikrochim Acta. 2015;182:119–127.
- Dor-Zidon S Metal-organic framework materials in gases delivery systems. (AU 2015/288367), 2017. Available from https://www.lens.org/lens/patent/119-746-306-176–444
- Gorayb SBS, Braz JRC, Martins RHC, et al. Inhaled gases humidification and heating during artificial ventilation with low flow and minimal fresh gases flow. Rev Bras Anestesiol. 2004;54(1):20–36.
- Horcajada P, Serre C, Vallet‐Regí M, et al. Metal-organic frameworks as efficient materials for drug delivery. Angew Chem Int Ed. 2006;45:5974–5978.
- Griffin SL, Champness NR. A periodic table of metal-organic frameworks. Coord Chem Rev. 2020;414:213295.
- Hoop M, Walde CF, Riccò R, et al. Biocompatibility characteristics of the metal organic framework ZIF-8 for therapeutical applications. Appl. Mater. Today. 2018;11:13-21. Available from: https://doi.org/10.1016/j.apmt.2017.12.014
- Wagner A, Liu Q, Rose OL, et al. Toxicity screening of two prevalent metal organic frameworks for therapeutic use in human lung epithelial cells. Int J Nanomedicine. 2019:14;7583-7591. Available from: https://doi.org/10.2147/IJN.S215950
- Tamames-Tabar C, Cunha D, Imbuluzqueta E, et al. Cytotoxicity of nanoscaled metal-organic frameworks. J Mater Chem B. 2014;2:262–271. Available from: https://doi.org/10.1039/C3TB20832J